The Needham Group
Skip Navigation
Home
Search
Client Access
About Us
News
Contact Us
About Us
Overview
Transaction History
Management
Careers
Firm Culture
Career Opportunities
Submit Resume
9/11 & Heroes Scholarship Fund
Institutional Sales & Trading
Overview
Sales
Trading
Equity Options Sales & Trading
Market Maker List
Team
Leadership
Sales
Trading
Conferences
Equity Research
Overview
Coverage Universe
Team
Leadership
Clean Technologies
Communications
Enterprise Infrastructure
Healthcare
Industrial & Diversified Growth
Internet, Entertainment & Consumer
Semiconductors & Equipment
Software & Services
Equity Research Client Login
Research Disclosures
Investment Banking
Overview
Corporate Finance
Industry Focus
Product Focus
Public Equity Offerings
Mergers & Acquisitions
Private Placements
Special Situations & Restructurings
Team
Leadership
Clean Technology
Communications
Enterprise Infrastructure
Financial Services
Healthcare
Industrial & Diversified Growth
Internet, Digital Media & Consumer
Semiconductors & Semi Equipment
Software & Services
Mergers & Acquisitions
Private Placements
Capital Markets
Corporate & Venture Services
Corporate Services
Executive Services
Venture Services
Team
Forms
Client Access
Private Capital
Transaction History
Asset Management
News
Needham Press Releases
Other Needham News
For Press & Media
Contact
New York
Boston
Chicago
Menlo Park
San Francisco
Isis Pharmaceuticals, Inc.
Company Name:
Isis Pharmaceuticals, Inc.
Sector:
Healthcare
Transaction Type:
Private Placement
Ticker Symbol:
ISIS
Deal Amount:
$201.3M
Transaction Date:
8/8/2012
Transaction Summary:
N/A
Company Description:
N/A
Back to Track Record